Last updated: April 24, 2026

Application No. 19/306,057

Untitled Application

Unknown

Filed

1600

Examiner

HUDSON, AMY ROSE

Art Unit

1636

Tech Center

NOVO NORDISK A/S

Assignee

Novo Nordisk A/S

OA Round

2 (Non-Final)

Interview Optional

— +11.3% interview lift. This examiner has a relatively high allow rate; a written response may suffice.

Based on 1433 resolved cases, 2023–2026

Examiner Intelligence

HUDSON, AMY ROSE View full profile →

Grants 75% — above average

Career Allow Rate

1077 granted / 1433 resolved

+15.2% vs TC avg

Moderate +11% lift

Without

With

+11.3%

Interview Lift

resolved cases with interview

Typical timeline

2y 7m

Avg Prosecution

62 currently pending

Career history

1495

Total Applications

across all art units

Statute-Specific Performance

§101

3.0%

-37.0% vs TC avg

§103

33.7%

-6.3% vs TC avg

§102

14.5%

-25.5% vs TC avg

§112

33.2%

-6.8% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1433 resolved cases

Prosecution Timeline

1600

Application Filed

Oct 20, 2025

Non-Final Rejection

Dec 05, 2025

Applicant Interview (Telephonic)

Dec 05, 2025

Examiner Interview Summary

Jan 22, 2026

Response Filed

Feb 12, 2026

Final Rejection

Apr 15, 2026

Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

17/981,146

Patent 12600969

EXPRESSION CONTROL USING A REGULATABLE INTRON

2y 5m to grant Granted Apr 14, 2026

17/440,438

Patent 12595479

ANTISENSE OLIGONUCLEOTIDE-BASED PROGRANULIN AUGMENTATION THERAPY IN NEURODEGENERATIVE DISEASES

2y 5m to grant Granted Apr 07, 2026

18/510,877

Patent 12595483

TREATMENT OF TUMORS WITH MIRNA TARGETING CDK4/CDK6

2y 5m to grant Granted Apr 07, 2026

17/523,009

Patent 12589133

METHODS OF DOWNREGULATING CCL20 GENES FOR TREATMENT OF TRAUMATIC BRAIN INJURIES

2y 5m to grant Granted Mar 31, 2026

17/630,671

Patent 12584132

NUCLEIC ACID DRUG TARGETING MURF1

2y 5m to grant Granted Mar 24, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.

Prosecution Projections

2-3

Expected OA Rounds

75%

Grant Probability

86%

With Interview (+11.3%)

2y 7m

Median Time to Grant

Moderate

PTA Risk

Based on 1433 resolved cases by this examiner. Grant probability derived from career allow rate.